Delivery Order SPE2DB22D1017-SPE2DB24FG2HC

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,590.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,472.64 to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $13,245.96 Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4566026495 HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This is not a set-aside contract. The contract has a firm fixed price and an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a ceiling value of $2,236.32 and a period of performance through March 18, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $1,863.60 to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $4,472.64 Firm Fixed Price contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. This Delivery Order does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $9,690.72 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML (NSN 4563928088) with an ultimate completion date of March 12, 2024. The $2,282.40 contract is not designated as a set-aside and is issued under a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, to deliver a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a potential value of $13,394.78 and a completion date of February 9, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,483.01 contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2HC
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,777.36 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation.

Generated 10/30/24, 10:04 AM